Ausgabe 1/2019
Inhalt (14 Artikel)
Effects of Cilostazol-Based Triple Antiplatelet Therapy Versus Dual Antiplatelet Therapy After Coronary Drug-Eluting Stent Implantation: An Updated Meta-Analysis of the Randomized Controlled Trials
Shijie Zhao, Zhaoshuang Zhong, Guoxian Qi, Liye Shi, Wen Tian
Is It Necessary to Perform the Pharmacological Interventions for Intrahepatic Cholestasis of Pregnancy? A Bayesian Network Meta-Analysis
Yi Shen, Jie Zhou, Sheng Zhang, Xu-Lin Wang, Yu-Long Jia, Shu He, Yuan-Yuan Wang, Wen-Chao Li, Jian-Guo Shao, Xun Zhuang, Yuan-Lin Liu, Gang Qin
Safety and Efficacy Profile of Neratinib: A Systematic Review and Meta-Analysis of 23 Prospective Clinical Trials
Zhihang Tao, Stanley Xiangyu Li, Kai Shen, Yunuo Zhao, Hao Zeng, Xuelei Ma
Impaired Renal Function May Not Negate the Efficacy of Tolvaptan in the Treatment of Cirrhotic Patients with Refractory Ascites
Yoshitaka Arase, Tatehiro Kagawa, Kota Tsuruya, Hirohiko Sato, Erika Teramura, Kazuya Anzai, Shunji Hirose, Ryuzo Deguchi, Koichi Shiraishi, Tetsuya Mine
Safety and Plasma Concentrations of a Cyclin-dependent Kinase 9 (CDK9) Inhibitor, FIT039, Administered by a Single Adhesive Skin Patch Applied on Normal Skin and Cutaneous Warts
Eriko Sumi, Takashi Nomura, Ryuta Asada, Ryuji Uozumi, Harue Tada, Yoko Amino, Teruo Sawada, Atsushi Yonezawa, Masatoshi Hagiwara, Kenji Kabashima
The Association between Polypharmacy and Hip Fracture in Osteoporotic Women: A Nested Case–Control Study in South Korea
Hae-Young Park, Suji Kim, Hyun Soon Sohn, Jin-Won Kwon
Physicians’ and Pharmacists’ Clinical Considerations for Elderly Patients with Type 2 Diabetes Mellitus: The IMPLICA2 Study
Josep Franch-Nadal, Fermín García-Gollarte, Alfonso Pérez del Molino, María L. Orera-Peña, Marta Rodríguez de Miguel, Malena Melogno-Klinkas, Héctor D. de Paz, Susana Aceituno, Patricia Rodríguez-Fortúnez
Pharmacokinetics, Safety and Tolerability of Tylerdipine Hydrochloride, a Novel Dihydropyridine Dual L/T-type Calcium Channel Blocker, after Single and Multiple Oral Doses in Healthy Chinese Subjects
Sufeng Zhou, Yuanyuan Wang, Lu Wang, Lijun Xie, Juan Chen, Yun Liu, Hongwen Zhang, Yuqing Zhao, Ning Ou, Feng Shao
Neuropsychological Assessment in Elderly Men with Benign Prostatic Hyperplasia Treated with Dutasteride
Antonino Catalano, Gabriella Martino, Federica Bellone, Maria Papalia, Carmen Lasco, Giorgio Basile, Alberto Sardella, Giacomo Nicocia, Nunziata Morabito, Antonino Lasco
Correction to: Neuropsychological Assessment in Elderly Men with Benign Prostatic Hyperplasia Treated with Dutasteride
Antonino Catalano, Gabriella Martino, Federica Bellone, Maria Papalia, Carmen Lasco, Giorgio Basile, Alberto Sardella, Giacomo Nicocia, Nunziata Morabito, Antonino Lasco
Comment on: Pharmacokinetics, Pharmacodynamics, and Safety of the Novel Calcimimetic Agent Evocalcet in Healthy Japanese Subjects: First-in-Human Phase I Study
Nuggehally R. Srinivas
Response to Comments on “Pharmacokinetics, Pharmacodynamics, and Safety of the Novel Calcimimetic Agent Evocalcet in Healthy Japanese Subjects: First-in-Human Phase I Study”
Tadao Akizawa, Ryutaro Shimazaki, Masanari Shiramoto, Masafumi Fukagawa
Correction to: Unexpected Benefit from Alpelisib and Fulvestrant in a Woman with Highly Pre-treated ER-Positive, HER2-Negative PIK3CA Mutant Metastatic Breast Cancer
Griet Hoste, Laurence Slembrouck, Lynn Jongen, Kevin Punie, Tom Matton, Sara Vander Borght, Isabelle Vanden Bempt, Johan Menten, Hans Wildiers, Giuseppe Floris, Carlos Arteaga, Patrick Neven
Correction to: Real-World Safety of Intravitreal Bevacizumab and Ranibizumab Treatments for Retinal Diseases in Thailand: A Prospective Observational Study
Sermsiri Sangroongruangsri, Usa Chaikledkaew, Suthasinee Kumluang, Olivia Wu, Claudia Geue, Tanapat Ratanapakorn, Pattara Leelahavarong, Lily Ingsrisawang, Paisan Ruamviboonsuk, Wongsiri Taweebanjongsin, Janejit Choovuthayakorn, Apichart Singalavanija, Prut Hanutsaha, Kittisak Kulvichit, Thitiporn Ratanapojnard, Warapat Wongsawad, Yot Teerawattananon